CorpDev.Org
Daily News for Dealmakers
Big Deal
Shell Denies BP Mega-Merger: Strategic Implications for the Energy Sector
Shell's swift denial of merger talks with BP marks a pivotal moment in energy sector consolidation, revealing deeper strategic realignments as oil giants navigate volatile markets. The proposed $80 billion acquisition would have created a $300...
Record M&A Insurance Payouts Signal Fundamental Shift in Transaction Risk Management
Aon's landmark Global Transaction Solutions Claims Study reveals unprecedented activity in representations and warranties (R&W) insurance, with North American clients recovering a record $300 million in paid claims during 2024 alone—the highest...
Carlyle’s Strategic Positioning in Europe’s $16 Trillion Defense Transformation
As Europe undergoes its largest military buildup since the Cold War, The Carlyle Group is strategically positioning itself to capitalize on unprecedented public-private defense partnerships. The European Union's €800 billion "ReArm Europe"...
Strategic Calculus: Apple’s AI Ambitions and Perplexity’s Acquisition Denial
Recent reports of Apple's potential acquisition of Perplexity AI have ignited industry speculation despite the startup's firm denial of any ongoing discussions. Internal deliberations within Apple, led by M&A chief Adrian Perica and services head...
BNY Mellon’s Strategic Gambit: Inside the Potential $87 Billion Custody Banking Merger
The Bank of New York Mellon's exploratory approach to Northern Trust represents a seismic shift in the custody banking landscape, potentially creating a $87 billion financial services powerhouse with combined assets under custody exceeding $70...
Top Jobs Currently Hiring
Thought Leadership
Private Equity
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Danone’s Strategic Acquisition of The Akkermansia Company: Accelerating Leadership in Next-Generation Biotics
Danone has significantly advanced its gut health research capabilities through the acquisition of The Akkermansia Company, a pioneer in next-generation probiotics and postbiotics. This strategic move enhances Danone's scientific portfolio with...
ProAssurance Stockholders Overwhelmingly Approve $1.3 Billion Acquisition by The Doctors Company
ProAssurance Corporation (NYSE: PRA) shareholders have delivered a decisive mandate for the company's acquisition by The Doctors Company, with over 99% of voting shares endorsing the $1.3 billion transaction that will create the nation's largest...
Surgery Partners’ Strategic Rejection: Why Independence Outweighed a $3.3B Buyout
The $3.3 billion standoff between Surgery Partners and Bain Capital represents a defining moment in healthcare private equity, revealing fundamental tensions between short-term liquidity events and long-term value creation in the rapidly evolving...
Eli Lilly’s Strategic Leap into Gene Editing: The $1.3 Billion Verve Therapeutics Acquisition and Its Cardiovascular Revolution
Eli Lilly's acquisition of Verve Therapeutics for up to $1.3 billion marks a watershed moment in the convergence of gene editing and cardiovascular therapeutics. This deal, announced on June 17, 2025, positions Lilly at the forefront of developing...
Pennsylvania House Votes to Scrutinize Private-Equity Healthcare Takeovers
The Pennsylvania House of Representatives has passed landmark legislation (House Bill 1460) imposing unprecedented oversight on private-equity healthcare transactions, marking a watershed moment in hospital M&A regulation . The bipartisan 121-82...
